From: Estimating prevalence of human traits among populations from polygenic risk scores
Super population | Population | Lactase persistence | Melanoma | Multiple sclerosis | Male height (cm) | Female height (cm) |
---|---|---|---|---|---|---|
AFR | ACB | – | 4.2 × 10–5 [12] | 175.9 [7] | 165.3 [7] | |
 | ASW | 0.25 [1] | 2.9 × 10–5 [18] | – | 175.5 [13] | 162.6 [13] |
 | ESN | 0.13 [59] | 5.7 × 10–6 [12] | 165.9 [7] | 156.3 [7] | |
 | GWD | 0.43 | 0 [12] | 165.4 [7] | 160.9 [7] | |
 | LWK | 0.61 [59] | 1.4 × 10–5 [12] | 169.6 [7] | 158.2 [7] | |
 | MSL | 0.52 | 5.6 × 10–6 [12] | 164.4 [7] | 156.6 [7] | |
 | YRI | 0.13 [59] | 5.7 × 10–6 [12] | 165.9 [7] | 156.3 [7] | |
AMR | CLM | 0.2 [59] | 1.08 × 10–4 [12] | 169.5 [7] | 156.95 [7] | |
 | MXL | 0.52 [59] | 6.9 × 10–5 [12] | 169.0 [7] | 156.9 [7] | |
 | Px10L | 0.06 [1] | 8.3 × 10–5 [12] | 165.2 [7] | 152.9 [7] | |
 | PUR | – | 1.11 × 10–4 [12] | 172.1 [7] | 159.2 [7] | |
EAS | CDX | 0.15 [59] | 1.5 × 10–5 [12] | 171.8 [7] | 159.7 [7] | |
 | CHB | 0.15 [59] | 1.5 × 10–5 [12] | 171.8 [7] | 159.7 [7] | |
 | CHS | 0.15 [59] | 1.5 × 10–5 [12] | 171.8 [7] | 159.7 [7] | |
 | JPT | 0.27 [59] | 5.0 × 10–5 [12] | 170.8 [7] | 158.3 [7] | |
 | KHV | 0.02 [59] | 4.3 × 10–6 [12] | 164.5 [7] | 153.6 [7] | |
EUR | CEU | 0.87 | 1.3 × 10–3 [18] | – | 177.4 [13] | 163.3 [13] |
 | FIN | 0.81[59] | 1.04 × 10–3 [12] | 179.6 [7] | 165.9 [7] | |
 | GBR | 0.92 [59] | 9.39 × 10–4 [12] | 177.5 [7] | 164.4 [7] | |
 | IBS | 0.71 [59] | 3.92 × 10–4 [12] | 176.6 [7] | 163.4 [7] | |
 | TSI | 0.28 [59] | 7.12 × 10–4 [12] | 177.8 [7] | 164.6 [7] | |
SAS | BEB | 0.175 | 6.5 × 10–6 [12] | 163.8 [7] | 150.8 [7] | |
 | GIH | 0.39 [59] | 5.4 × 10–6 [12] | 165.0 [7] | 152.6 [7] | |
 | ITU | 0.39 [59] | 5.4 × 10–6 [12] | 165.0 [7] | 152.6 [7] | |
 | PJL | 0.42 [59] | 4.6 × 10–6 [12] | 167.0 [7] | 153.8 [7] | |
 | STU | 0.27 [59] | 1.4 × 10–5 [12] | 165.7 [7] | 154.6 [7] |